Go Pro

Ultralife (ULBI) Competitors

Ultralife logo
$5.51 -0.04 (-0.72%)
Closing price 04:00 PM Eastern
Extended Trading
$5.52 +0.00 (+0.09%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ULBI vs. NPWR, MVST, SES, RONI, and SKYX

Should you buy Ultralife stock or one of its competitors? MarketBeat compares Ultralife with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ultralife include NET Power (NPWR), Microvast (MVST), SES AI (SES), Rice Acquisition Corp. II (RONI), and SKYX Platforms (SKYX). These companies are all part of the "electrical equipment" industry.

How does Ultralife compare to NET Power?

NET Power (NYSE:NPWR) and Ultralife (NASDAQ:ULBI) are both small-cap electrical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Ultralife has higher revenue and earnings than NET Power. Ultralife is trading at a lower price-to-earnings ratio than NET Power, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NET Power$250K1,395.89-$578.63M-$5.89N/A
Ultralife$191.16M0.48-$5.90M-$0.50N/A

NET Power has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

NET Power currently has a consensus target price of $3.50, suggesting a potential upside of 125.08%. Given NET Power's stronger consensus rating and higher possible upside, research analysts clearly believe NET Power is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NET Power
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

NET Power has a net margin of 0.00% compared to Ultralife's net margin of -4.37%. NET Power's return on equity of 133.74% beat Ultralife's return on equity.

Company Net Margins Return on Equity Return on Assets
NET PowerN/A 133.74% 43.90%
Ultralife -4.37%1.15%0.70%

In the previous week, Ultralife had 3 more articles in the media than NET Power. MarketBeat recorded 3 mentions for Ultralife and 0 mentions for NET Power. Ultralife's average media sentiment score of 0.17 beat NET Power's score of 0.00 indicating that Ultralife is being referred to more favorably in the news media.

Company Overall Sentiment
NET Power Neutral
Ultralife Neutral

53.6% of NET Power shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 2.1% of NET Power shares are owned by insiders. Comparatively, 42.9% of Ultralife shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

NET Power beats Ultralife on 10 of the 16 factors compared between the two stocks.

How does Ultralife compare to Microvast?

Microvast (NASDAQ:MVST) and Ultralife (NASDAQ:ULBI) are both small-cap electrical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Ultralife has a net margin of -4.37% compared to Microvast's net margin of -11.52%. Ultralife's return on equity of 1.15% beat Microvast's return on equity.

Company Net Margins Return on Equity Return on Assets
Microvast-11.52% -6.12% -2.43%
Ultralife -4.37%1.15%0.70%

Microvast has a beta of 3.48, suggesting that its share price is 248% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

In the previous week, Ultralife had 1 more articles in the media than Microvast. MarketBeat recorded 3 mentions for Ultralife and 2 mentions for Microvast. Microvast's average media sentiment score of 1.74 beat Ultralife's score of 0.17 indicating that Microvast is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microvast
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Ultralife
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

20.7% of Microvast shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 44.8% of Microvast shares are owned by company insiders. Comparatively, 42.9% of Ultralife shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Ultralife has lower revenue, but higher earnings than Microvast. Ultralife is trading at a lower price-to-earnings ratio than Microvast, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microvast$427.52M0.70-$29.22M-$0.32N/A
Ultralife$191.16M0.48-$5.90M-$0.50N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microvast
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Microvast beats Ultralife on 8 of the 14 factors compared between the two stocks.

How does Ultralife compare to SES AI?

Ultralife (NASDAQ:ULBI) and SES AI (NYSE:SES) are both small-cap electrical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

SES AI has a consensus target price of $2.70, indicating a potential upside of 323.20%. Given SES AI's stronger consensus rating and higher possible upside, analysts clearly believe SES AI is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SES AI
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Ultralife has higher revenue and earnings than SES AI. Ultralife is trading at a lower price-to-earnings ratio than SES AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$191.16M0.48-$5.90M-$0.50N/A
SES AI$21M11.14-$73.04M-$0.22N/A

Ultralife has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, SES AI has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market.

Ultralife has a net margin of -4.37% compared to SES AI's net margin of -331.72%. Ultralife's return on equity of 1.15% beat SES AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-4.37% 1.15% 0.70%
SES AI -331.72%-28.65%-23.21%

30.7% of Ultralife shares are owned by institutional investors. Comparatively, 29.8% of SES AI shares are owned by institutional investors. 42.9% of Ultralife shares are owned by company insiders. Comparatively, 13.8% of SES AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Ultralife had 2 more articles in the media than SES AI. MarketBeat recorded 3 mentions for Ultralife and 1 mentions for SES AI. Ultralife's average media sentiment score of 0.17 beat SES AI's score of 0.00 indicating that Ultralife is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ultralife
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SES AI
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Ultralife beats SES AI on 9 of the 16 factors compared between the two stocks.

How does Ultralife compare to Rice Acquisition Corp. II?

Ultralife (NASDAQ:ULBI) and Rice Acquisition Corp. II (NYSE:RONI) are both small-cap electrical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Rice Acquisition Corp. II has lower revenue, but higher earnings than Ultralife.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$191.16M0.48-$5.90M-$0.50N/A
Rice Acquisition Corp. IIN/AN/A$4.07MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Rice Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Rice Acquisition Corp. II has a net margin of 0.00% compared to Ultralife's net margin of -4.37%. Ultralife's return on equity of 1.15% beat Rice Acquisition Corp. II's return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-4.37% 1.15% 0.70%
Rice Acquisition Corp. II N/A -17.93%-4.49%

In the previous week, Ultralife had 3 more articles in the media than Rice Acquisition Corp. II. MarketBeat recorded 3 mentions for Ultralife and 0 mentions for Rice Acquisition Corp. II. Ultralife's average media sentiment score of 0.17 beat Rice Acquisition Corp. II's score of 0.00 indicating that Ultralife is being referred to more favorably in the media.

Company Overall Sentiment
Ultralife Neutral
Rice Acquisition Corp. II Neutral

Ultralife has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Rice Acquisition Corp. II has a beta of 0.01, indicating that its stock price is 99% less volatile than the broader market.

30.7% of Ultralife shares are held by institutional investors. Comparatively, 22.5% of Rice Acquisition Corp. II shares are held by institutional investors. 42.9% of Ultralife shares are held by company insiders. Comparatively, 20.0% of Rice Acquisition Corp. II shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Ultralife beats Rice Acquisition Corp. II on 9 of the 11 factors compared between the two stocks.

How does Ultralife compare to SKYX Platforms?

Ultralife (NASDAQ:ULBI) and SKYX Platforms (NASDAQ:SKYX) are both small-cap electrical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

30.7% of Ultralife shares are owned by institutional investors. Comparatively, 11.8% of SKYX Platforms shares are owned by institutional investors. 42.9% of Ultralife shares are owned by insiders. Comparatively, 24.2% of SKYX Platforms shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Ultralife has higher revenue and earnings than SKYX Platforms. Ultralife is trading at a lower price-to-earnings ratio than SKYX Platforms, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$191.16M0.48-$5.90M-$0.50N/A
SKYX Platforms$92.01M1.72-$33.42M-$0.29N/A

Ultralife has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, SKYX Platforms has a beta of -3527.1, indicating that its share price is 352,810% less volatile than the broader market.

SKYX Platforms has a consensus target price of $5.00, indicating a potential upside of 323.73%. Given SKYX Platforms' stronger consensus rating and higher possible upside, analysts plainly believe SKYX Platforms is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SKYX Platforms
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67

Ultralife has a net margin of -4.37% compared to SKYX Platforms' net margin of -35.79%. Ultralife's return on equity of 1.15% beat SKYX Platforms' return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-4.37% 1.15% 0.70%
SKYX Platforms -35.79%N/A -52.05%

In the previous week, Ultralife had 2 more articles in the media than SKYX Platforms. MarketBeat recorded 3 mentions for Ultralife and 1 mentions for SKYX Platforms. SKYX Platforms' average media sentiment score of 1.20 beat Ultralife's score of 0.17 indicating that SKYX Platforms is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ultralife
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SKYX Platforms
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Ultralife beats SKYX Platforms on 9 of the 17 factors compared between the two stocks.

Get Ultralife News Delivered to You Automatically

Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ULBI vs. The Competition

MetricUltralifeELEC IndustryComputer SectorNASDAQ Exchange
Market Cap$92.44M$6.85B$38.28B$12.43B
Dividend YieldN/A1.62%3.14%8.84%
P/E Ratio-11.0245.27168.7923.89
Price / Sales0.483.42596.8492.04
Price / Cash9.2226.2744.7960.07
Price / Book0.703.519.296.18
Net Income-$5.90M$191.37M$1.07B$331.73M
7 Day Performance-5.81%-3.41%-2.64%-2.29%
1 Month Performance-12.40%-10.87%-2.27%-1.62%
1 Year Performance-37.60%46.98%135.68%16.81%

Ultralife Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ULBI
Ultralife
1.5808 of 5 stars
$5.51
-0.7%
N/A-35.5%$92.44M$191.16MN/A560
NPWR
NET Power
2.1673 of 5 stars
$1.49
+2.4%
$3.50
+135.7%
-45.6%$325.40M$250KN/A24
MVST
Microvast
1.3292 of 5 stars
$0.97
-0.5%
N/A-70.1%$325.03M$427.52MN/A1,908
SES
SES AI
1.8968 of 5 stars
$0.71
+0.5%
$2.70
+283.0%
-35.5%$257.11M$21MN/A130
RONI
Rice Acquisition Corp. II
N/A$1.45
-7.1%
N/A-47.3%$175.09MN/AN/A24

Related Companies and Tools


This page (NASDAQ:ULBI) was last updated on 7/17/2026 by MarketBeat.com Staff.
From Our Partners